tradingkey.logo

Sarepta Therapeutics Provides Update On Elevidys

ReutersApr 4, 2025 12:50 PM

- Sarepta Therapeutics Inc SRPT.O:

  • SAREPTA THERAPEUTICS PROVIDES UPDATE ON ELEVIDYS

  • SAREPTA THERAPEUTICS: STUDIES AFFECTED BY TEMPORARY HALT ARE STUDY SRP-9001-302 (ENVOL), STUDY SRP-9001-303 (ENVISION), STUDY SRP-9001-104

  • SAREPTA THERAPEUTICS: CO, ROCHE WILL SUBMIT INFORMATION IN RESPONSE TO TEMPORARY HALT WITHIN WEEK

  • SAREPTA THERAPEUTICS INC -DO NOT ANTICIPATE A MATERIAL IMPACT ON TIMELINE FOR SRP-9001-302, SRP-9001-303, SRP-9001-104 STUDIES

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI